Reasons, Efficacy and Safety of Switching to Dolutegravir-Based Regimens Among Virologically Suppressed PLWH: A Retrospective Cohort Study of 96 Weeks

Deng M, Chen N, Lao X, Wang X, Fu J, Xing L, Zhao H

Infection and Drug Resistance 2024, 17:1571-1582

Published Date: 23 April 2024